Aug 5, 2026 05:49PM
Aug 5, 2026 04:28PM
Jul 22, 2026 01:36PM
May 11, 2026 04:05PM
May 11, 2026 04:05PM
May 4, 2026 09:30AM
Mar 10, 2026 08:15AM Oppenheimer Reiterates Outperform Rating on Coherus Biosciences (CHRS): "buying opportunity ahead of key catalysts"
Mar 9, 2026 04:24PM
Mar 9, 2026 04:15PM
Mar 2, 2026 09:30AM
Jan 5, 2026 09:30AM
Jan 5, 2026 09:30AM
Dec 8, 2025 08:32AM
Dec 8, 2025 08:30AM Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma
Nov 7, 2025 09:00AM
Nov 7, 2025 09:00AM
Nov 6, 2025 04:27PM
Nov 6, 2025 04:14PM
Oct 30, 2025 08:30AM
Oct 3, 2025 09:05AM
Aug 7, 2025 04:43PM Coherus BioSciences (CHRS) Misses Q2 EPS by 8c
Aug 7, 2025 04:41PM
Jul 31, 2025 04:45PM
May 13, 2025 07:28AM
May 12, 2025 04:15PM
Apr 28, 2025 10:14AM
Apr 28, 2025 10:10AM
Apr 1, 2025 08:02AM Coherus BioSciences (CHRS) Announces Repurchase of Approximately $170M of Convertible Notes
Apr 1, 2025 08:00AM
Mar 10, 2025 04:15PM
Mar 10, 2025 04:12PM
Nov 6, 2024 05:23PM
Aug 8, 2024 04:52PM
Aug 8, 2024 04:05PM
May 9, 2024 04:05PM Coherus BioSciences (CHRS) Misses Q1 EPS by 7c, provides R&D and SG&A expense guidance
Mar 13, 2024 04:16PM
Mar 13, 2024 04:05PM
Jan 18, 2024 04:53PM
Nov 6, 2023 04:21PM
Nov 6, 2023 04:07PM
Oct 30, 2023 08:17AM
Aug 31, 2023 04:01PM Surface Oncology (SURF) Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences (CHRS)
Aug 31, 2023 04:01PM
Aug 2, 2023 04:13PM
May 1, 2023 04:07PM
Mar 6, 2023 04:04PM
Mar 6, 2023 04:01PM
Feb 28, 2023 08:25AM
Nov 8, 2022 04:04PM Coherus BioSciences (CHRS) Misses Q3 EPS by 22c, Misses on Revenue
Nov 8, 2022 04:01PM

1,217,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All